CC趋化因子CCL3、CCL4和CCL5与利什曼原虫前鞭毛体之间直接相互作用的证据。 - Suppr

Suppr

超能文献

Evidence of direct interactions between the CC-chemokines CCL3, CCL4 and CCL5 and Leishmania promastigotes.

作者信息

Roychoudhury Kaushik, Dasgupta Biplab, Sen Pradip, Laskay Tamás, Solbach Werner, De Tripti, Roy Syamal

机构信息

Indian Institute of Chemical Biology, Kolkata 700032, India.

出版信息

Mol Biochem Parasitol. 2006 Dec;150(2):374-7. doi: 10.1016/j.molbiopara.2006.08.009. Epub 2006 Sep 14.

DOI:10.1016/j.molbiopara.2006.08.009

PMID:17005260

Abstract

摘要

相似文献

Evidence of direct interactions between the CC-chemokines CCL3, CCL4 and CCL5 and Leishmania promastigotes.

Mol Biochem Parasitol. 2006 Dec;150(2):374-7. doi: 10.1016/j.molbiopara.2006.08.009. Epub 2006 Sep 14.

The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients.

Thromb Res. 2008;122(3):328-35. doi: 10.1016/j.thromres.2007.10.017. Epub 2007 Nov 28.

The role of CD26/DPP IV in chemokine processing.

Chem Immunol. 1999;72:42-56.

Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells.

Arthritis Res Ther. 2006;8(2):R50. doi: 10.1186/ar1913. Epub 2006 Feb 28.

CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.

Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2370-6. doi: 10.1161/ATVBAHA.107.147009. Epub 2007 Aug 23.

Structures of human CCL18, CCL3, and CCL4 reveal molecular determinants for quaternary structures and sensitivity to insulin-degrading enzyme.

J Mol Biol. 2015 Mar 27;427(6 Pt B):1345-1358. doi: 10.1016/j.jmb.2015.01.012. Epub 2015 Jan 28.

Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4.

J Leukoc Biol. 2004 May;75(5):901-9. doi: 10.1189/jlb.0403136. Epub 2004 Feb 3.

Leptin enhances CC-chemokine ligand expression in cultured murine macrophage.

Biochem Biophys Res Commun. 2009 Jul 3;384(3):311-5. doi: 10.1016/j.bbrc.2009.04.121. Epub 2009 May 3.

Serial measurements of levels of the chemokines CCL2, CCL3 and CCL5 in serum of patients with acute ischaemic stroke.

Folia Neuropathol. 2006;44(4):282-9.

Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.

Biochem Pharmacol. 2007 Sep 15;74(6):881-90. doi: 10.1016/j.bcp.2007.06.019. Epub 2007 Jun 20.

引用本文的文献

Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).

PLoS Negl Trop Dis. 2012;6(6):e1703. doi: 10.1371/journal.pntd.0001703. Epub 2012 Jun 19.

Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications.

Pharmacol Ther. 2010 Apr;126(1):39-55. doi: 10.1016/j.pharmthera.2009.12.003. Epub 2010 Feb 1.

Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.

Infect Immun. 2009 Jun;77(6):2330-42. doi: 10.1128/IAI.00057-09. Epub 2009 Mar 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Evidence of direct interactions between the CC-chemokines CCL3, CCL4 and CCL5 and Leishmania promastigotes.

作者信息

Roychoudhury Kaushik, Dasgupta Biplab, Sen Pradip, Laskay Tamás, Solbach Werner, De Tripti, Roy Syamal

机构信息

Indian Institute of Chemical Biology, Kolkata 700032, India.

出版信息

Mol Biochem Parasitol. 2006 Dec;150(2):374-7. doi: 10.1016/j.molbiopara.2006.08.009. Epub 2006 Sep 14.

DOI:10.1016/j.molbiopara.2006.08.009

PMID:17005260

Abstract

摘要

相似文献

Evidence of direct interactions between the CC-chemokines CCL3, CCL4 and CCL5 and Leishmania promastigotes.

Mol Biochem Parasitol. 2006 Dec;150(2):374-7. doi: 10.1016/j.molbiopara.2006.08.009. Epub 2006 Sep 14.

The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients.

Thromb Res. 2008;122(3):328-35. doi: 10.1016/j.thromres.2007.10.017. Epub 2007 Nov 28.

The role of CD26/DPP IV in chemokine processing.

Chem Immunol. 1999;72:42-56.

Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells.

Arthritis Res Ther. 2006;8(2):R50. doi: 10.1186/ar1913. Epub 2006 Feb 28.

CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.

Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2370-6. doi: 10.1161/ATVBAHA.107.147009. Epub 2007 Aug 23.

Structures of human CCL18, CCL3, and CCL4 reveal molecular determinants for quaternary structures and sensitivity to insulin-degrading enzyme.

J Mol Biol. 2015 Mar 27;427(6 Pt B):1345-1358. doi: 10.1016/j.jmb.2015.01.012. Epub 2015 Jan 28.

Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4.

J Leukoc Biol. 2004 May;75(5):901-9. doi: 10.1189/jlb.0403136. Epub 2004 Feb 3.

Leptin enhances CC-chemokine ligand expression in cultured murine macrophage.

Biochem Biophys Res Commun. 2009 Jul 3;384(3):311-5. doi: 10.1016/j.bbrc.2009.04.121. Epub 2009 May 3.

Serial measurements of levels of the chemokines CCL2, CCL3 and CCL5 in serum of patients with acute ischaemic stroke.

Folia Neuropathol. 2006;44(4):282-9.

Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.

Biochem Pharmacol. 2007 Sep 15;74(6):881-90. doi: 10.1016/j.bcp.2007.06.019. Epub 2007 Jun 20.

引用本文的文献

Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).

PLoS Negl Trop Dis. 2012;6(6):e1703. doi: 10.1371/journal.pntd.0001703. Epub 2012 Jun 19.

Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications.

Pharmacol Ther. 2010 Apr;126(1):39-55. doi: 10.1016/j.pharmthera.2009.12.003. Epub 2010 Feb 1.

Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.

Infect Immun. 2009 Jun;77(6):2330-42. doi: 10.1128/IAI.00057-09. Epub 2009 Mar 16.